Management of solid tumours in organ-transplant recipients.
Malignancy is a well-recognised complication of transplantation and can occur de novo, as a recurrence of a pre-existing malignancy, or from transmission of malignancy from the donor. Common de-novo malignancies are those of the skin and the lymphoreticular system. Various solid-organ cancers have also been reported in transplant recipients and each poses a unique management challenge in view of the unusual setting. We review solid-organ cancers in transplant recipients and their management, including surveillance and prevention.
Ajithkumar
Thankamma V
TV
Department of Oncology, Bristol Haematology and Oncology Centre, Bristol, UK. tvajith@hotmail.com
Parkinson
Christine A
CA
Butler
Andrew
A
Hatcher
Helen M
HM
D006801:Humans; D007108:Immune Tolerance; D015994:Incidence; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D016377:Organ Transplantation / Q000009:adverse effects*; D014019:Tissue Donors